Aptahem AB logo

APTA TO 5 - Aptahem AB News Story

SEK0.1 0.0  0.0%

Last Trade - 13/04/21

Sector
Healthcare
Size
Micro Cap
Market Cap £6.60m
Enterprise Value £4.18m
Revenue £n/a
Position in Universe 1664th / 1828

BRIEF-Aptahem Signs Non Binding Term Sheet For Development, Manufacturing And Distribution Of Apta-1 For Sepsis In Europe

Tue 9th March, 2021 1:23pm
March 9 (Reuters) - Aptahem AB  APTA.TE :
    * APTAHEM SIGNS A NON BINDING TERM SHEET FOR DEVELOPMENT,
MANUFACTURING AND DISTRIBUTION OF APTA-1 FOR SEPSIS IN EUROPE
    * ANNOUNCE TODAY THAT COMPANY HAS SIGNED AN NBTS (NON
BINDING TERM
SHEET) WITH A MID-SIZED PHARMACEUTICAL COMPANY WITH HEAD
QUARTERS IN EUROPE.
    * NBTS RELATES TO LICENSE TERMS FOR EXCLUSIVE DEVELOPMENT,
MANUFACTURING AND DISTRIBUTION OF APTA-1 FOR TREATMENT OF SEPSIS
IN EUROPE.

Source text for Eikon:  ID:nWkr4VtlcD 
Further company coverage:  APTA.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.